129 related articles for article (PubMed ID: 11115712)
1. Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults.
Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
Vaccine; 2000 Nov; 19(7-8):886-94. PubMed ID: 11115712
[TBL] [Abstract][Full Text] [Related]
2. Association of time since pneumococcal polysaccharide vaccine receipt and CD4 count with antibody response to the 13-valent pneumococcal conjugate vaccine in HIV-infected adults.
Rossheim AE; Young AM; Siik J; Cunningham TD; Troy SB
Hum Vaccin Immunother; 2016 Aug; 12(8):2117-2123. PubMed ID: 27172241
[TBL] [Abstract][Full Text] [Related]
3. Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults.
Peñaranda M; Payeras A; Cambra A; Mila J; Riera M;
AIDS; 2010 May; 24(8):1226-8. PubMed ID: 20299956
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
[TBL] [Abstract][Full Text] [Related]
5. Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy.
Lu CL; Hung CC; Chuang YC; Liu WC; Su CT; Su YC; Chang SF; Chang SY; Chang SC
Hum Vaccin Immunother; 2013 Feb; 9(2):398-404. PubMed ID: 23291936
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations.
Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
Vaccine; 1999 Oct; 18(5-6):524-30. PubMed ID: 10519943
[TBL] [Abstract][Full Text] [Related]
7. Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.
Abzug MJ; Song LY; Levin MJ; Nachman SA; Borkowsky W; Pelton SI;
Vaccine; 2013 Oct; 31(42):4782-90. PubMed ID: 23954381
[TBL] [Abstract][Full Text] [Related]
8. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial.
Ahmed F; Steinhoff MC; Rodriguez-Barradas MC; Hamilton RG; Musher DM; Nelson KE
J Infect Dis; 1996 Jan; 173(1):83-90. PubMed ID: 8537687
[TBL] [Abstract][Full Text] [Related]
9. Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.
Miiro G; Kayhty H; Watera C; Tolmie H; Whitworth JA; Gilks CF; French N
J Infect Dis; 2005 Nov; 192(10):1801-5. PubMed ID: 16235180
[TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.
Crum-Cianflone NF; Huppler Hullsiek K; Roediger M; Ganesan A; Patel S; Landrum ML; Weintrob A; Agan BK; Medina S; Rahkola J; Hale BR; Janoff EN;
J Infect Dis; 2010 Oct; 202(7):1114-25. PubMed ID: 20795819
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.
McFetridge R; Meulen AS; Folkerth SD; Hoekstra JA; Dallas M; Hoover PA; Marchese RD; Zacholski DM; Watson WJ; Stek JE; Hartzel JS; Musey LK
Vaccine; 2015 Jun; 33(24):2793-9. PubMed ID: 25913828
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients.
Lu CL; Hung CC; Chuang YC; Liu WC; Su CT; Hsiao CF; Tseng YT; Su YC; Chang SF; Chang SY; Chang SC
Vaccine; 2012 May; 30(24):3526-33. PubMed ID: 22484349
[TBL] [Abstract][Full Text] [Related]
13. Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.
Sigurdardottir ST; Center KJ; Davidsdottir K; Arason VA; Hjalmarsson B; Elisdottir R; Ingolfsdottir G; Northington R; Scott DA; Jonsdottir I
Vaccine; 2014 Jan; 32(3):417-24. PubMed ID: 24300594
[TBL] [Abstract][Full Text] [Related]
14. A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.
Hung CC; Chang SY; Su CT; Chen YY; Chang SF; Yang CY; Liu WC; Wu CH; Chang SC
HIV Med; 2010 Jan; 11(1):54-63. PubMed ID: 19659943
[TBL] [Abstract][Full Text] [Related]
15. Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.
Feikin DR; Elie CM; Goetz MB; Lennox JL; Carlone GM; Romero-Steiner S; Holder PF; O'Brien WA; Whitney CG; Butler JC; Breiman RF
Clin Diagn Lab Immunol; 2004 Jan; 11(1):137-41. PubMed ID: 14715560
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children.
Madhi SA; Kuwanda L; Cutland C; Holm A; Käyhty H; Klugman KP
Pediatr Infect Dis J; 2005 May; 24(5):410-6. PubMed ID: 15876939
[TBL] [Abstract][Full Text] [Related]
17. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults.
Feikin DR; Elie CM; Goetz MB; Lennox JL; Carlone GM; Romero-Steiner S; Holder PF; O'Brien WA; Whitney CG; Butler JC; Breiman RF
Vaccine; 2001 Nov; 20(3-4):545-53. PubMed ID: 11672921
[TBL] [Abstract][Full Text] [Related]
19. Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults.
Ohtola JA; Khaskhely NM; Saul-Mcbeth JL; Iyer AS; Leggat DJ; Khuder SA; Westerink MAJ
Vaccine; 2016 Jan; 34(4):451-457. PubMed ID: 26707220
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.
Lee KY; Tsai MS; Kuo KC; Tsai JC; Sun HY; Cheng AC; Chang SY; Lee CH; Hung CC
Hum Vaccin Immunother; 2014; 10(12):3700-10. PubMed ID: 25483681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
